Pear Therapeutics, Inc. announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Operating Officer, will present at Oppenheimer’s 29th Annual Healthcare Conference in New York on Tuesday, March 19 at 9:45 a.m. Eastern Time.
March 13, 2019
· 1 min read